Core Viewpoint - The company Jiejia Weichuang (SZ 300724) expects a significant increase in net profit for the first half of 2025, projecting a range of 1.7 billion to 1.96 billion yuan, representing a year-on-year growth of 38.65% to 59.85% due to the conversion of orders into revenue [2] Group 1 - The projected net profit for the first half of 2025 is between 1.7 billion and 1.96 billion yuan [2] - The year-on-year growth rate for the projected net profit is between 38.65% and 59.85% [2] - The main reason for the profit increase is the continuous acceptance and conversion of orders into revenue during the reporting period [2] Group 2 - For the year 2024, the company's revenue composition is entirely from solar cell production equipment, accounting for 100% [2]

Group 1 - Jiejia Weichuang expects a net profit of 1.7 billion to 1.96 billion yuan for the first half of 2025, representing a year-on-year increase of 38.65% to 59.85% [1] - Micron Biotech's CS231295 clinical trial application has been approved by the FDA for treating advanced solid tumors [1] - Sinopec anticipates a net profit of 20.1 billion to 21.6 billion yuan for the first half of 2025, a decrease of 39.5% to 43.7% year-on-year [2] Group 2 - High Energy Environment has obtained a loan commitment letter from a financial institution for share repurchase [2] - Electric Power Investment Energy received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inadequate disclosure in its semi-annual report [3] - Zhejiang University Net New won a bid for an intelligent engineering project worth 94.2712 million yuan [5] Group 3 - Daodaoquan reported a net profit of 181 million yuan for the first half of 2025, a year-on-year increase of 563.15% [8] - New Light Optoelectronics expects a net loss of 19 million to 23 million yuan for the first half of 2025 [9] - Aihua Pharmaceutical's two probiotic powder registration applications have been accepted [10] Group 4 - Xinhui Electric's subsidiary signed a product sales framework contract for commercial and household robots [11] - Baida Precision Engineering's subsidiary obtained 134,500 square meters of industrial land use rights [12] - Haiyang Technology's chief engineer resigned for personal reasons [13] Group 5 - Tianhe Magnetic Materials received a project filing notice for a 12,000-ton magnetic material deep processing project [22] - Wanlima is the pre-selected unit for a procurement project worth 43.835 million yuan from China Southern Airlines [24] - Yipin Hong's subsidiaries obtained two drug registration certificates [25] Group 6 - Zhejiang Jiaoke's subsidiary signed new construction projects worth 4.783 billion yuan in the second quarter [27] - Shenglan Co. received approval for issuing convertible bonds [29] - Jimi Technology expects a net profit of 88.6622 million yuan for the first half of 2025, a year-on-year increase of 2062.33% [31] Group 7 - Dingtong Technology reported a net profit of 115 million yuan for the first half of 2025, a year-on-year increase of 134.06% [32] - Huaheng Biological is planning to list on the Hong Kong Stock Exchange [34] - Yuntian Lihui submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [36] Group 8 - Nanchip Technology expects a net profit of 108.8 million to 133.1 million yuan for the first half of 2025, a decrease of 35.09% to 47.03% year-on-year [43] - Anglikang's Mesobam injection has received a drug registration certificate [44] - Jida Zhengyuan's shareholder plans to reduce their stake by up to 0.998% [45]

格隆汇7月31日丨捷佳伟创(300724.SZ)公布2025年半年度业绩预告，1-6月公司实现归属于上市公司股东 的净利润盈利17亿元–19.6亿元，比上年同期增长38.65%–59.85%；扣除非经常性损益后的净利润盈利 15.49亿元–18.09亿元，比上年同期增长31.37%–53.41%。业绩变动原因为公司在手订单在报告期内持续 验收转化为收入所致。 ...

7月31日，捷佳伟创公告，预计2025年上半年归母净利润17亿元–19.6亿元，同比增长38.65%–59.85%。 ...

公告称，业绩变动原因系公司在手订单在报告期内持续验收转化为收入所致。 智通财经APP讯，捷佳伟创(300724.SZ)披露2025年半年度业绩预告，公司预计归属于上市公司股东的净 利润17亿元至19.6亿元，同比增长38.65%至59.85%;扣除非经常性损益后的净利润15.49亿元至18.09亿 元，同比增长31.37%至53.41%。 ...

（文章来源：每日经济新闻） 每经AI快讯，7月31日，捷佳伟创(300724.SZ)公告称，2025年半年度预计归属于上市公司股东的净利润 为17亿元~19.6亿元，比上年同期增长38.65%~59.85%。业绩增长主要原因是公司在手订单在报告期内持 续验收转化为收入。 ...

格隆汇7月31日丨捷佳伟创(300724.SZ)公布2025年半年度业绩预告，1-6月公司实现归属于上市公司股东 的净利润盈利17亿元–19.6亿元，比上年同期增长38.65%–59.85%；扣除非经常性损益后的净利润盈利 15.49亿元–18.09亿元，比上年同期增长31.37%–53.41%。业绩变动原因为公司在手订单在报告期内持续 验收转化为收入所致。 ...

人民财讯7月31日电，捷佳伟创（300724）7月31日晚间发布业绩预告，预计2025年上半年归母净利17亿 元—19.6亿元，同比增长38.65%—59.85%。业绩增长得益于公司在手订单在报告期内持续验收转化为收 入。 ...

格隆汇7月31日｜捷佳伟创(300724.SZ)公告称，2025年半年度预计归属于上市公司股东的净利润为17亿 元–19.6亿元，比上年同期增长38.65%–59.85%。业绩增长主要原因是公司在手订单在报告期内持续验收 转化为收入。 ...

Core Viewpoint - The company expects a significant increase in net profit for the first half of 2025, driven by the conversion of existing orders into revenue [1] Financial Performance - The net profit attributable to shareholders is projected to be between 1.7 billion and 1.96 billion yuan, representing a year-on-year growth of 38.65% to 59.85% [1] - The net profit after deducting non-recurring gains and losses is expected to be between 1.549 billion and 1.809 billion yuan, indicating a year-on-year increase of 31.37% to 53.41% [1] Revenue Drivers - The anticipated growth in performance is primarily due to the company's ability to continuously convert its backlog of orders into revenue during the reporting period [1]